Altered Molecular Regulation of TUG Is a Central Feature of Insulin-Resistant Human Adipose Tissue

There is a paucity of data regarding defects in insulin signaling in insulin-resistant human white adipose tissue (WAT). The tether containing a UBX domain for GLUT4 (TUG) protein, which retains GLUT4 vesicles, was increased in WAT of participants with greater insulin resistance in three different cohorts with obesity. Components of the TUG regulatory signaling pathway were differentially expressed between participants with greater insulin resistance and those with greater insulin sensitivity. TUG may provide an important pharmacologic target in the treatment or prevention of metabolic dysfunction in patients with obesity.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-12-05
DOI
https://doi.org/10.2337/db25-0488
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Altered Molecular Regulation of TUG Is a Central Feature of Insulin-Resistant Human Adipose Tissue

Aldo Jongejan, Daniel F. Vatner, Steven R. Shuken, Jordan W. Strober et al.
Diabetes
Metabolism, Diabetes, and Cancer
article

Altered Molecular Regulation of TUG Is a Central Feature of Insulin-Resistant Human Adipose Tissue

Aldo Jongejan, Daniel F. Vatner, Steven R. Shuken, Jordan W. Strober, Sonia Caprio, João A. Paulo, Aaron L. Slusher, Mireille J. Serlie, Nicola Santoro, Jonathan S. Bogan, Elena Tarabra, Steven P. Gygi, Daeun Sung, Brandon M. Gassaway, Kasper W. ter Horst
article en

Abstract

There is a paucity of data regarding defects in insulin signaling in insulin-resistant human white adipose tissue (WAT). The tether containing a UBX domain for GLUT4 (TUG) protein, which retains GLUT4 vesicles, was increased in WAT of participants with greater insulin resistance in three different cohorts with obesity. Components of the TUG regulatory signaling pathway were differentially expressed between participants with greater insulin resistance and those with greater insulin sensitivity. TUG may provide an important pharmacologic target in the treatment or prevention of metabolic dysfunction in patients with obesity.

DiabetesVol. 75(2)
Brigham Young University (US), Harvard University (US), Veterans Health Administration (US), Yale University (US), Department of Veterans Affairs (AU), Amsterdam University Medical Centers (NL), Harvard Stem Cell Institute (US), University of Amsterdam (NL)
Openalex Percentile: Top 65%
Metabolism, Diabetes, and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.